About this Research Topic
The aim of this research topic is to highlight the most advanced studies on the molecular pathogenesis of SARS-CoV-2 co-infection with influenza or other respiratory pathogens, providing great insight into the epidemiology, transmission, diagnosis, therapies, and vaccines. We welcome the submission of Original Research, Brief Research Report, Review, and Mini-Review articles that address these issues.
Submissions to this topic may include, but are not necessarily limited to, the following sub-topics:
1. Viral evolution, molecular epidemiology, and ecology in SARS-CoV-2 co-infection with influenza or other pathogens
2. Viral transmission and associated molecular marker in SARS-CoV-2 coinfection with influenza viruses or other respiratory pathogens
3. Pathogenesis, virus-host interaction, cell tropism, and immune response in SARS-CoV-2 co-infection with influenza viruses or other respiratory pathogens
4. The dynamics of host microbiome, virome, and fungiome in SARS-CoV-2 co-infection with influenza viruses or other respiratory pathogens
5. Development of therapeutic strategies including antiviral drugs, antibodies, and other treatments against influenza and SARS-CoV-2 co-infection and the molecular mechanism
6. Development of vaccines including vaccination strategies, vaccine strain selection, characterization, and optimization against influenza and SARS-CoV-2 co-infection
Keywords: Pathogenesis, SARS-CoV-2, COVID-19, Influenza, Treatments
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.